IP Library Assignment 058217/0192
Patent Assignment
Reel/Frame 058217/0192

Assignment of Assignor's Interest

Recorded: 2021-11-27 Pages: 5
Assignor
MIHARA, RYOSUKE
Executed: 2020-09-06
Assignee
CHUGAI SEIYAKU KABUSHIKI KAISHA
5-1, UKIMA 5-CHOME, KITA-KU, TOKYO, 115-8543, JAPAN
Covered Property (1)
Nemolizumab in the Treatment of Atopic Dermatitis with Moderate to Severe Excoriation
Application: 16/988,554 →
Publication: US 2020/0385476
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 27, 2021
From: KERROUCHE, NABIL
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 058217/0169 →
Assignment of Assignor's Interest Nov 27, 2021
From: KERROUCHE, NABIL
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 058217/0184 →
Assignment of Assignor's Interest Nov 27, 2021
From: HIROKAWA, KEIKO
To: CHUGAI SEIYAKU KABUSHIKI KAISHA
Reel/Frame 058217/0187 →
Change of Name Nov 27, 2021
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 058217/0201 →
Corrective Assignment to Correct the Application Number 16907132 Previously Recorded at Reel: 058217 Frame: 0169. Assignor(S) Hereby Confirms the Assignment . Apr 28, 2022
From: KERROUCHE, NABIL
To: NESTLE SKIN HEALTH SA
Reel/Frame 059820/0089 →
Change of Address Jun 27, 2022
From: GALDERMA HOLDING SA
To: GALDERMA HOLDING SA
Reel/Frame 061113/0710 →